Subscribe To

Price Alert Latest News Economic Calendar News

MVMDF / Mountain Valley MD licenses modified ivermectin product to treat fish and wildlife for parasites in Bangladesh

Mountain Valley MD has agreed to a license its parasitic infection treatment Soluvec 1% to a private Ontario company that intends to use it for animal husbandry applications in Bangladesh. The agreement allows the licensee to coordinate Soluvec 1% manufacturing and distribution of related Soluvec 1% products, both in injectable and food coating applications, within the country. Read More

Demo Live Account See Partner Details

Content Topics

Mountain

Valley

Licenses

Modified

Ivermectin

Product

Treat

Wildlife

Parasites

Bangladesh

Stock

MVMDF

Posted: May 8 2023, 10:42

Author Name: Proactive Investors

MVMDF News

By Proactive Investors
September 8, 2023

Mountain Valley MD appoints Lucie Letellier as new CFO

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) announced it has appointed Lucie Letellier to replace Aaron Triplett as its chief financial of

By Proactive Investors
August 11, 2023

Mountain Valley MD highlights progress in core business lines

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it continues to progress in commercializing its three core lines of business. “The MVMD

By Proactive Investors
May 8, 2023

Mountain Valley MD licenses modified ivermectin product to treat fish and wildlife for parasites in Bangladesh

Mountain Valley MD has agreed to a license its parasitic infection treatment Soluvec 1% to a private Ontario company that intends to use it for animal

By Proactive Investors
November 29, 2022

Mountain Valley MD highlights shift to commercially focused biotech with revenue-generating activities in business update

Mountain Valley MD Holdings Inc (CSE:MVMD, OTCQB:MVMDF) said it has shifted focus to the commercialization strategy for those of its projects and tech

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.